Uterine and Adnexal Procedures for Non-Malignancy

Principal Diagnosis - Pdx

  • A18.16 Tuberculosis of cervix
  • A18.17 Tuberculous female pelvic inflammatory disease
  • A18.18 Tuberculosis of other female genital organs
  • A51.0 Primary genital syphilis
  • A54.00 Gonococcal infection of lower genitourinary tract, unspecified
  • A54.02 Gonococcal vulvovaginitis, unspecified
  • A54.03 Gonococcal cervicitis, unspecified
  • A54.09 Other gonococcal infection of lower genitourinary tract
  • A54.1 Gonococcal infection of lower genitourinary tract with periurethral and accessory gland abscess
  • A54.21 Gonococcal infection of kidney and ureter
  • A54.24 Gonococcal female pelvic inflammatory disease
  • A54.29 Other gonococcal genitourinary infections
  • A55 Chlamydial lymphogranuloma (venereum)
  • A56.00 Chlamydial infection of lower genitourinary tract, unspecified
  • A56.01 Chlamydial cystitis and urethritis
  • A56.02 Chlamydial vulvovaginitis
  • A56.09 Other chlamydial infection of lower genitourinary tract
  • A56.2 Chlamydial infection of genitourinary tract, unspecified
  • A56.8 Sexually transmitted chlamydial infection of other sites
  • A57 Chancroid
  • A58 Granuloma inguinale
  • A59.00 Urogenital trichomoniasis, unspecified
  • A59.01 Trichomonal vulvovaginitis
  • A59.03 Trichomonal cystitis and urethritis
  • A59.09 Other urogenital trichomoniasis
  • A60.00 Herpesviral infection of urogenital system, unspecified
  • A60.03 Herpesviral cervicitis
  • A60.04 Herpesviral vulvovaginitis
  • A60.09 Herpesviral infection of other urogenital tract
  • A60.1 Herpesviral infection of perianal skin and rectum
  • A60.9 Anogenital herpesviral infection, unspecified
  • A63.8 Other specified predominantly sexually transmitted diseases
  • A64 Unspecified sexually transmitted disease
  • B37.3 Candidiasis of vulva and vagina
  • B37.41 Candidal cystitis and urethritis
  • B37.49 Other urogenital candidiasis
  • D25.0 Submucous leiomyoma of uterus
  • D25.1 Intramural leiomyoma of uterus
  • D25.2 Subserosal leiomyoma of uterus
  • D25.9 Leiomyoma of uterus, unspecified
  • D26.0 Other benign neoplasm of cervix uteri
  • D26.1 Other benign neoplasm of corpus uteri
  • D26.7 Other benign neoplasm of other parts of uterus
  • D26.9 Other benign neoplasm of uterus, unspecified
  • D27.0 Benign neoplasm of right ovary
  • D27.1 Benign neoplasm of left ovary
  • D27.9 Benign neoplasm of unspecified ovary
  • D28.0 Benign neoplasm of vulva
  • D28.1 Benign neoplasm of vagina
  • D28.2 Benign neoplasm of uterine tubes and ligaments
  • D28.7 Benign neoplasm of other specified female genital organs
  • D28.9 Benign neoplasm of female genital organ, unspecified
  • E28.0 Estrogen excess
  • E28.1 Androgen excess
  • E28.2 Polycystic ovarian syndrome
  • E28.310 Symptomatic premature menopause
  • E28.319 Asymptomatic premature menopause
  • E28.39 Other primary ovarian failure
  • E28.8 Other ovarian dysfunction
  • E28.9 Ovarian dysfunction, unspecified
  • E89.40 Asymptomatic postprocedural ovarian failure
  • E89.41 Symptomatic postprocedural ovarian failure
  • F52.5 Vaginismus not due to a substance or known physiological condition
  • I86.2 Pelvic varices
  • I86.3 Vulval varices
  • L29.2 Pruritus vulvae
  • L29.3 Anogenital pruritus, unspecified
  • N34.1 Nonspecific urethritis
  • N39.3 Stress incontinence (female) (male)
  • N70.01 Acute salpingitis
  • N70.02 Acute oophoritis
  • N70.03 Acute salpingitis and oophoritis
  • N70.11 Chronic salpingitis
  • N70.12 Chronic oophoritis
  • N70.13 Chronic salpingitis and oophoritis
  • N70.91 Salpingitis, unspecified
  • N70.92 Oophoritis, unspecified
  • N70.93 Salpingitis and oophoritis, unspecified
  • N71.0 Acute inflammatory disease of uterus
  • N71.1 Chronic inflammatory disease of uterus
  • N71.9 Inflammatory disease of uterus, unspecified
  • N72 Inflammatory disease of cervix uteri
  • N73.0 Acute parametritis and pelvic cellulitis
  • N73.1 Chronic parametritis and pelvic cellulitis
  • N73.2 Unspecified parametritis and pelvic cellulitis
  • N73.3 Female acute pelvic peritonitis
  • N73.4 Female chronic pelvic peritonitis
  • N73.5 Female pelvic peritonitis, unspecified
  • N73.6 Female pelvic peritoneal adhesions (postinfective)
  • N73.8 Other specified female pelvic inflammatory diseases
  • N73.9 Female pelvic inflammatory disease, unspecified
  • N74 Female pelvic inflammatory disorders in diseases classified elsewhere
  • N75.0 Cyst of Bartholin's gland
  • N75.1 Abscess of Bartholin's gland
  • N75.8 Other diseases of Bartholin's gland
  • N75.9 Disease of Bartholin's gland, unspecified
  • N76.0 Acute vaginitis
  • N76.1 Subacute and chronic vaginitis
  • N76.2 Acute vulvitis
  • N76.3 Subacute and chronic vulvitis

Operating / Non-Operating Room Procedures

  • 015P0ZZ Destruction of Sacral Sympathetic Nerve, Open Approach
  • 015P3ZZ Destruction of Sacral Sympathetic Nerve, Percutaneous Approach
  • 015P4ZZ Destruction of Sacral Sympathetic Nerve, Percutaneous Endoscopic Approach
  • 0U15075 Bypass Right Fallopian Tube to Right Fallopian Tube with Autologous Tissue Substitute, Open Approach
  • 0U15076 Bypass Right Fallopian Tube to Left Fallopian Tube with Autologous Tissue Substitute, Open Approach
  • 0U15079 Bypass Right Fallopian Tube to Uterus with Autologous Tissue Substitute, Open Approach
  • 0U150J5 Bypass Right Fallopian Tube to Right Fallopian Tube with Synthetic Substitute, Open Approach
  • 0U150J6 Bypass Right Fallopian Tube to Left Fallopian Tube with Synthetic Substitute, Open Approach
  • 0U150J9 Bypass Right Fallopian Tube to Uterus with Synthetic Substitute, Open Approach
  • 0U150K5 Bypass Right Fallopian Tube to Right Fallopian Tube with Nonautologous Tissue Substitute, Open Approach
  • 0U150K6 Bypass Right Fallopian Tube to Left Fallopian Tube with Nonautologous Tissue Substitute, Open Approach
  • 0U150K9 Bypass Right Fallopian Tube to Uterus with Nonautologous Tissue Substitute, Open Approach
  • 0U150Z5 Bypass Right Fallopian Tube to Right Fallopian Tube, Open Approach
  • 0U150Z6 Bypass Right Fallopian Tube to Left Fallopian Tube, Open Approach
  • 0U150Z9 Bypass Right Fallopian Tube to Uterus, Open Approach
  • 0U15475 Bypass Right Fallopian Tube to Right Fallopian Tube with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
  • 0U15476 Bypass Right Fallopian Tube to Left Fallopian Tube with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
  • 0U15479 Bypass Right Fallopian Tube to Uterus with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
  • 0U154J5 Bypass Right Fallopian Tube to Right Fallopian Tube with Synthetic Substitute, Percutaneous Endoscopic Approach
  • 0U154J6 Bypass Right Fallopian Tube to Left Fallopian Tube with Synthetic Substitute, Percutaneous Endoscopic Approach
  • 0U154J9 Bypass Right Fallopian Tube to Uterus with Synthetic Substitute, Percutaneous Endoscopic Approach
  • 0U154K5 Bypass Right Fallopian Tube to Right Fallopian Tube with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
  • 0U154K6 Bypass Right Fallopian Tube to Left Fallopian Tube with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
  • 0U154K9 Bypass Right Fallopian Tube to Uterus with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
  • 0U154Z5 Bypass Right Fallopian Tube to Right Fallopian Tube, Percutaneous Endoscopic Approach
  • 0U154Z6 Bypass Right Fallopian Tube to Left Fallopian Tube, Percutaneous Endoscopic Approach
  • 0U154Z9 Bypass Right Fallopian Tube to Uterus, Percutaneous Endoscopic Approach
  • 0U16075 Bypass Left Fallopian Tube to Right Fallopian Tube with Autologous Tissue Substitute, Open Approach
  • 0U16076 Bypass Left Fallopian Tube to Left Fallopian Tube with Autologous Tissue Substitute, Open Approach
  • 0U16079 Bypass Left Fallopian Tube to Uterus with Autologous Tissue Substitute, Open Approach
  • 0U160J5 Bypass Left Fallopian Tube to Right Fallopian Tube with Synthetic Substitute, Open Approach
  • 0U160J6 Bypass Left Fallopian Tube to Left Fallopian Tube with Synthetic Substitute, Open Approach
  • 0U160J9 Bypass Left Fallopian Tube to Uterus with Synthetic Substitute, Open Approach
  • 0U160K5 Bypass Left Fallopian Tube to Right Fallopian Tube with Nonautologous Tissue Substitute, Open Approach
  • 0U160K6 Bypass Left Fallopian Tube to Left Fallopian Tube with Nonautologous Tissue Substitute, Open Approach
  • 0U160K9 Bypass Left Fallopian Tube to Uterus with Nonautologous Tissue Substitute, Open Approach
  • 0U160Z5 Bypass Left Fallopian Tube to Right Fallopian Tube, Open Approach
  • 0U160Z6 Bypass Left Fallopian Tube to Left Fallopian Tube, Open Approach
  • 0U160Z9 Bypass Left Fallopian Tube to Uterus, Open Approach
  • 0U16475 Bypass Left Fallopian Tube to Right Fallopian Tube with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
  • 0U16476 Bypass Left Fallopian Tube to Left Fallopian Tube with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
  • 0U16479 Bypass Left Fallopian Tube to Uterus with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
  • 0U164J5 Bypass Left Fallopian Tube to Right Fallopian Tube with Synthetic Substitute, Percutaneous Endoscopic Approach
  • 0U164J6 Bypass Left Fallopian Tube to Left Fallopian Tube with Synthetic Substitute, Percutaneous Endoscopic Approach
  • 0U164J9 Bypass Left Fallopian Tube to Uterus with Synthetic Substitute, Percutaneous Endoscopic Approach
  • 0U164K5 Bypass Left Fallopian Tube to Right Fallopian Tube with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
  • 0U164K6 Bypass Left Fallopian Tube to Left Fallopian Tube with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
  • 0U164K9 Bypass Left Fallopian Tube to Uterus with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
  • 0U164Z5 Bypass Left Fallopian Tube to Right Fallopian Tube, Percutaneous Endoscopic Approach
  • 0U164Z6 Bypass Left Fallopian Tube to Left Fallopian Tube, Percutaneous Endoscopic Approach
  • 0U164Z9 Bypass Left Fallopian Tube to Uterus, Percutaneous Endoscopic Approach
  • 0U500ZZ Destruction of Right Ovary, Open Approach
  • 0U503ZZ Destruction of Right Ovary, Percutaneous Approach
  • 0U504ZZ Destruction of Right Ovary, Percutaneous Endoscopic Approach
  • 0U508ZZ Destruction of Right Ovary, Via Natural or Artificial Opening Endoscopic
  • 0U510ZZ Destruction of Left Ovary, Open Approach
  • 0U513ZZ Destruction of Left Ovary, Percutaneous Approach
  • 0U514ZZ Destruction of Left Ovary, Percutaneous Endoscopic Approach
  • 0U518ZZ Destruction of Left Ovary, Via Natural or Artificial Opening Endoscopic
  • 0U520ZZ Destruction of Bilateral Ovaries, Open Approach
  • 0U523ZZ Destruction of Bilateral Ovaries, Percutaneous Approach
  • 0U524ZZ Destruction of Bilateral Ovaries, Percutaneous Endoscopic Approach
  • 0U528ZZ Destruction of Bilateral Ovaries, Via Natural or Artificial Opening Endoscopic
  • 0U540ZZ Destruction of Uterine Supporting Structure, Open Approach
  • 0U543ZZ Destruction of Uterine Supporting Structure, Percutaneous Approach
  • 0U544ZZ Destruction of Uterine Supporting Structure, Percutaneous Endoscopic Approach
  • 0U548ZZ Destruction of Uterine Supporting Structure, Via Natural or Artificial Opening Endoscopic
  • 0U550ZZ Destruction of Right Fallopian Tube, Open Approach
  • 0U553ZZ Destruction of Right Fallopian Tube, Percutaneous Approach
  • 0U554ZZ Destruction of Right Fallopian Tube, Percutaneous Endoscopic Approach
  • 0U557ZZ Destruction of Right Fallopian Tube, Via Natural or Artificial Opening
  • 0U558ZZ Destruction of Right Fallopian Tube, Via Natural or Artificial Opening Endoscopic
  • 0U560ZZ Destruction of Left Fallopian Tube, Open Approach
  • 0U563ZZ Destruction of Left Fallopian Tube, Percutaneous Approach
  • 0U564ZZ Destruction of Left Fallopian Tube, Percutaneous Endoscopic Approach
  • 0U567ZZ Destruction of Left Fallopian Tube, Via Natural or Artificial Opening
  • 0U568ZZ Destruction of Left Fallopian Tube, Via Natural or Artificial Opening Endoscopic
  • 0U590ZZ Destruction of Uterus, Open Approach
  • 0U593ZZ Destruction of Uterus, Percutaneous Approach
  • 0U594ZZ Destruction of Uterus, Percutaneous Endoscopic Approach
  • 0U597ZZ Destruction of Uterus, Via Natural or Artificial Opening
  • 0U598ZZ Destruction of Uterus, Via Natural or Artificial Opening Endoscopic
  • 0U5B0ZZ Destruction of Endometrium, Open Approach
  • 0U5B3ZZ Destruction of Endometrium, Percutaneous Approach
  • 0U5B4ZZ Destruction of Endometrium, Percutaneous Endoscopic Approach
  • 0U5B7ZZ Destruction of Endometrium, Via Natural or Artificial Opening
  • 0U5B8ZZ Destruction of Endometrium, Via Natural or Artificial Opening Endoscopic
  • 0U750DZ Dilation of Right Fallopian Tube with Intraluminal Device, Open Approach
  • 0U750ZZ Dilation of Right Fallopian Tube, Open Approach
  • 0U753DZ Dilation of Right Fallopian Tube with Intraluminal Device, Percutaneous Approach
  • 0U753ZZ Dilation of Right Fallopian Tube, Percutaneous Approach
  • 0U754DZ Dilation of Right Fallopian Tube with Intraluminal Device, Percutaneous Endoscopic Approach
  • 0U754ZZ Dilation of Right Fallopian Tube, Percutaneous Endoscopic Approach
  • 0U757DZ Dilation of Right Fallopian Tube with Intraluminal Device, Via Natural or Artificial Opening
  • 0U757ZZ Dilation of Right Fallopian Tube, Via Natural or Artificial Opening
  • 0U758DZ Dilation of Right Fallopian Tube with Intraluminal Device, Via Natural or Artificial Opening Endoscopic
  • 0U758ZZ Dilation of Right Fallopian Tube, Via Natural or Artificial Opening Endoscopic
  • 0U760DZ Dilation of Left Fallopian Tube with Intraluminal Device, Open Approach
  • 0U760ZZ Dilation of Left Fallopian Tube, Open Approach
  • 0U763DZ Dilation of Left Fallopian Tube with Intraluminal Device, Percutaneous Approach